Flurbiprofen : List of nationally authorised medicinal products - PSUSA/00001450/202211
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Ovarian Neoplasms;Sarcoma, Kaposi;Multiple Myeloma, Date of authorisation: 31/05/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Breast Neoplasms;Ovarian Neoplasms;Multiple Myeloma;Sarcoma, Kaposi, Date of authorisation: 15/09/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Sarcoma, Kaposi;Multiple Myeloma;Ovarian Neoplasms;Breast Neoplasms, Date of authorisation: 20/06/1996, Revision: 36, Status: Authorised
Checklist for the submission of day +5 translations for a post-opinion linguistic review - veterinary
QRD Form 2 and checklist for the submission of day +25 files - veterinary
QRD Form 2 and checklist for the submission of day +25 files - veterinary
QRD Form 1 - veterinary
Eleventh Nitrosamine Implementation Oversight Group (NIOG) meeting, Online, from 12/07/2023 to 12/07/2023
The linguistic review process of product information in the centralised procedure - veterinary